welcome to oneEDSvoice- a positively charged Ehlers Danlos Syndrome community.
- join today!
Lawrence Afrin, MD
Professor of Medicine
Division of Hematology, Oncology and Transplantation
University of Minnesota
420 Delaware Street SE
Minneapolis, Minnesota, United States
Dr. Lawrence Afrin earned a B.S. in Computer Science at Clemson University in 1984 and then an M.D. at the Medical University of South Carolina (MUSC) in 1988, where he also pursued internal medicine residency and hematology/oncology clinical and research fellowships. While on faculty at MUSC 1995-2014, he was active in undergraduate and graduate medical education, educational and IT administration, and practice and research in hematology/oncology and medical informatics. Since the mid-’00s, his clinical work has increasingly focused in hematology, especially mast cell disease; he also directed MUSC’s myeloproliferative neoplasms clinical trials program. He joined the University of Minnesota in 2014. He has served on national panels on oncology education and quality care and speaks widely in his areas of focus. He has an extensive record of peer-reviewed publications and serves on the editorial boards for several journals and on the Medical Advisory Board for The Mastocytosis Society.
expertly curated content related to this topic
Cervical Artery Dissection: An Atypical Presentation with Ehlers-Danlos-Like Collagen Pathology?The authors took skin biopsies of the ma...
Haploinsufficiency of the Murine Col3a1 Locus Causes Aortic Dissection: A Novel Model of the Vascular Type of Ehlers...AIMS: The vascular type of Ehlers-Danlo...
Acer Therapeutics Inc.Acer Therapeutics is a biotech company, ...
Diana Lebron, MDDiana Lebron, MD, is a well known heada...
Howard Levy, MD, PhDDr. Levy is dedicated to patient care, e...
Michele Moscato, DODr. Moscato completed her undergraduate ...
Acer Therapeutics Obtains Exclusive License to Celiprolol Pivotal Clinical Data from AP-HP“We have studied celiprolol for nearly...